No definition available.
Endpoint definition
↥
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
520210 |
1. Apply sex-specific ruleNone |
520210 |
2. Check conditionsNone |
520210 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters: 2 out of 7 registries used, show all original rules. |
98 |
4. Check minimum number of eventsNone |
98 |
5. Include endpointsNone |
98 |
6. Filter based on genotype QC (FinnGen only) |
98 |
Control definitions (FinnGen only)
Controls for this endpoint are individuals that are not cases.
Extra metadata
- First used in FinnGen datafreeze
- DF5
Similar endpoints
↥List of similar endpoints to
Sleepwalking [somnambulism]
based on the number of shared cases.
Similar with more cases:
- Nonorganic sleeping disorders
- Nonorganic sleeping disorders, excluding more controls
- Sleep disorders
- Behavioural syndromes associated with physiological disturbances and physical factors
- Sleep disorders (combined)
Similar with less cases:
None
Case counts by codes
↥
Summary Statistics
↥-FinRegistry-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | |||
| Whole population | 741 | 345 | 395 |
| Only index persons | 706 | 334 | 372 |
| Unadjusted period prevalence (%) | |||
| Whole population | 0.01 | 0.01 | 0.01 |
| Only index persons | 0.01 | 0.01 | 0.01 |
| Median age at first event (years) | |||
| Whole population | 24.02 | 29.30 | 19.39 |
| Only index persons | 24.31 | 29.66 | 19.51 |
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 98 | 69 | 29 |
| Unadjusted period prevalence (%) | 0.02 | 0.02 | 0.01 |
| Median age at first event (years) | 34.44 | 37.36 | 27.49 |
-FinRegistry-
Age distribution of first events
-FinnGen-
Age distribution of first events
-FinRegistry-
Year distribution of first events
-FinnGen-
Year distribution of first events
-FinRegistry-
Cumulative Incidence Function
-FinnGen-
Cumulative Incidence Function
No data
CodeWAS (R11)
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 84
- Matched controls
- 838
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
F51.3
ICD-10 Finland
Sleepwalking [somnambulism]
+∞
120.9
84
*
G47.9
ICD-10 Finland
Sleep disorder, unspecified
40.2
15.6
19
6
F51.9
ICD-10 Finland
Nonorganic sleep disorder, unspecified
34.5
9.7
12
*
IAB13
NOMESCO Finland
Psychiatric sleep disorder consultation
+∞
9.5
9
*
N03AE01
ATC
clonazepam; systemic
11.7
7.9
14
14
N06AX11
ATC
mirtazapine; oral
3.6
6.5
36
143
F51.4
ICD-10 Finland
Sleep terrors [night terrors]
+∞
6.3
6
*
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(42870588) Differential panel, method unspecified - Blood
42
239
2.33
3.93
4.4
5.9
—
—
—
0
0
(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection
7
8
9.31
3.84
1.1
1.0
—
—
—
0
0
(43054903) Holo-transcobalamin II [Moles/volume] in Serum
42
245
2.25
3.66
1.7
1.8
pmol/l
103.0
97.3
0.31
22
130
(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count
40
232
2.22
3.50
3.4
2.7
—
—
—
0
0
(3006418) Campylobacter sp identified in Tissue by Organism specific culture
10
27
4.01
3.45
1.0
1.1
—
—
—
0
0
(3014765) Yersinia sp identified in Stool by Organism specific culture
10
28
3.86
3.29
1.0
1.1
—
—
—
0
0
(3000492) Spirometry study
19
81
2.67
3.23
1.4
1.2
—
—
—
0
0
(42529406) Shigella sp [Presence] in Stool by Culture
10
29
3.73
3.14
1.0
1.2
—
—
—
0
0
(3018095) Leukocytes [#/volume] in Urine
42
259
2.09
3.07
3.7
3.1
e6/l
23.0
47.0
0.49
30
175
(3025941) Bacteria identified in Stool by Culture
13
46
3.11
3.05
1.3
1.2
—
—
—
0
0
(3002582) Erythrocytes [#/volume] in Urine
36
214
2.08
2.87
3.3
2.5
e6/l
11.2
75.7
1.42
28
163
(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma
47
311
1.98
2.77
2.1
2.4
nmol/l
72.7
71.7
0.10
47
284
(40768804) Tissue Pathology biopsy report
47
311
1.98
2.77
1.7
1.9
—
—
—
0
0
(3029634) Reagin Ab [Titer] in Serum by VDRL
6
10
6.31
2.74
1.2
1.4
—
—
—
0
0
(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection
12
44
2.97
2.65
1.3
1.7
—
—
—
0
0
(40758558) Short blood count panel - Blood
32
187
2.06
2.64
7.1
6.4
—
—
—
0
0
(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay
5
7
7.45
2.58
1.0
1.3
—
—
—
0
0
(3031040) Bacteria [#/volume] in Urine by Automated count
65
491
1.96
2.51
4.7
4.1
—
39.5
—
0
6
(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count
23
121
2.18
2.47
2.3
2.1
e6/l
1.8
0.8
—
9
62
(3021589) Normoblasts [#/volume] in Blood
50
349
1.88
2.43
6.7
7.9
e9/l
0.0
0.0
0.00
42
289
(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum
37
234
1.93
2.42
1.5
1.3
u/ml
1.3
1.2
0.07
12
57
(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma
15
66
2.50
2.38
2.8
1.8
u/l
319.4
4893.0
—
7
19
(3000991) Gas panel - Venous blood
10
35
3.07
2.38
21.9
10.0
—
—
—
0
0
(3030467) Casts [#/volume] in Urine by Automated count
32
197
1.93
2.25
3.4
2.5
e6/l
0.3
0.1
0.51
24
143
(3010380) Borrelia burgdorferi IgG Ab [Units/volume] in Cerebral spinal fluid
5
9
5.78
2.24
1.0
1.0
—
—
—
0
0
(3013115) Eosinophils [#/volume] in Blood
55
404
1.82
2.21
6.3
6.1
e9/l
0.2
0.2
0.06
50
367
(3006315) Basophils [#/volume] in Blood
53
389
1.79
2.10
6.3
5.7
e9/l
0.0
0.0
0.04
48
351
(3001604) Monocytes [#/volume] in Blood
53
389
1.79
2.10
6.3
5.7
e9/l
0.5
0.5
1.27
48
351
(3014973) Borrelia burgdorferi IgM Ab [Units/volume] in Cerebral spinal fluid
5
10
5.20
2.09
1.0
1.0
—
—
—
0
0
(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count
21
114
2.07
2.07
2.3
2.2
e6/l
4.9
2.8
—
8
56
(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay
6
15
4.19
2.07
1.2
1.1
—
—
—
0
0
(3018251) Fasting glucose [Moles/volume] in Serum or Plasma
81
683
2.07
2.00
4.0
3.4
mmol/l
5.8
5.6
0.74
74
639
(36304419) Bacteria [Presence] in Urine
32
204
1.84
2.00
3.5
2.4
—
—
—
0
0
(3015736) pH of Urine
44
310
1.76
1.97
3.6
2.7
—
—
—
0
0
(3037467) Urinalysis macro (dipstick) panel - Urine
67
535
1.80
1.92
3.8
4.1
—
—
—
0
0
(40761535) Cells panel - Urine sediment
10
40
2.67
1.90
5.0
2.7
—
—
—
0
0
(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma
31
199
1.82
1.88
2.1
2.8
ng/l
11.8
67.7
0.97
16
99
(40768797) Stomach Pathology biopsy report
17
89
2.10
1.84
1.3
1.2
—
—
—
0
0
(3007164) IgA [Mass/volume] in Serum or Plasma
32
209
1.79
1.83
1.4
1.3
g/l
2.2
2.1
0.01
18
118
(3021601) Nitrite [Presence] in Urine by Test strip
51
381
1.71
1.82
5.2
4.5
estimate
0.0
0.0
0.00
12
80
(3003327) Ova and parasites identified in Stool by Light microscopy
10
41
2.60
1.82
1.6
1.6
—
—
—
0
0
(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma
26
160
1.85
1.80
1.5
2.0
mg/l
0.6
0.7
0.26
18
114
(40761511) CBC panel - Blood by Automated count
93
850
2.84
1.79
10.4
9.5
—
—
—
0
0
(3011288) Drugs identified in Urine by Screen method
13
62
2.26
1.75
2.0
1.8
—
—
—
0
0
(3020779) Urea [Moles/volume] in Serum or Plasma
8
31
2.72
1.70
1.4
7.5
mmol/l
4.9
7.1
—
8
31
(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection
37
257
1.71
1.70
2.4
2.6
—
—
—
0
0
(3016543) Leukocytes [#/volume] in Cerebral spinal fluid
6
19
3.29
1.69
1.3
1.2
e6/l
0.3
2.2
—
6
14
(3024889) Methemoglobin/Hemoglobin.total in Venous blood
6
19
3.29
1.69
1.3
1.7
%
0.6
0.6
—
6
19
(3009261) Glucose [Presence] in Urine by Test strip
51
388
1.66
1.65
4.2
3.1
estimate
0.0
0.0
0.00
12
75
(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection
8
32
2.63
1.63
2.1
1.4
—
—
—
0
0
(3019539) Treponema pallidum Ab [Titer] in Serum by Hemagglutination
5
14
3.70
1.63
1.2
1.4
—
—
—
0
0
(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection
5
14
3.70
1.63
1.0
1.8
—
—
—
0
0
(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma
15
79
2.06
1.60
1.7
2.8
umol/l
3.3
4.8
1.04
15
66
(3022145) Colonoscopy Study observation
15
80
2.03
1.55
1.1
1.5
—
—
—
0
0
(3052851) Hemolysis interference index of Serum or Plasma
5
15
3.45
1.54
1.2
1.7
—
—
—
0
0
(3014148) Varicella zoster virus Ab [Titer] in Serum
5
15
3.45
1.54
1.4
1.3
—
—
—
0
0
(3010517) Carboxyhemoglobin/Hemoglobin.total in Venous blood
6
21
2.97
1.53
1.3
1.9
%
0.9
1.4
—
6
21
(44816559) Phosphatidylethanol [Mass/volume] in Blood
7
28
2.61
1.48
1.3
1.2
—
—
—
0
0
(3020460) C reactive protein [Mass/volume] in Serum or Plasma
89
808
2.10
1.48
13.7
10.5
mg/l
19.2
21.9
0.31
71
611
(3044889) 12 lead EKG panel
55
437
1.59
1.42
3.0
3.0
—
—
—
0
0
(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma
36
259
1.62
1.41
3.1
2.9
u/l
22.9
28.6
1.78
36
242
(3032080) INR in Blood by Coagulation assay
29
198
1.66
1.39
1.9
6.1
inr
1.0
1.1
2.55
13
72
(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal
13
69
2.02
1.36
1.0
1.0
—
—
—
0
0
(3013650) Neutrophils [#/volume] in Blood by Automated count
56
454
1.54
1.28
9.6
8.0
e9/l
3.6
4.1
1.92
51
402
(3035350) Ketones [Presence] in Urine by Test strip
49
386
1.54
1.27
4.2
3.0
estimate
0.0
0.0
0.00
12
77
(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma
67
567
1.57
1.25
3.5
2.7
u/l
29.0
35.2
0.97
62
545
(3011397) Hemoglobin [Presence] in Urine by Test strip
24
160
1.66
1.25
4.5
3.0
—
—
—
0
0
(3012516) Albumin [Mass/volume] in Urine
21
135
1.71
1.24
3.6
3.4
mg/l
9.4
124.0
1.26
15
87
(3023368) Bacteria identified in Blood by Culture
23
152
1.67
1.23
4.2
4.3
—
—
—
0
0
(3026493) Urate [Moles/volume] in Serum or Plasma
22
144
1.68
1.22
1.8
2.7
umol/l
288.1
3057.4
0.50
17
130
(3002385) Erythrocyte distribution width [Ratio]
81
721
1.71
1.18
14.4
12.5
%
13.3
13.3
0.18
81
713
(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)
81
722
1.70
1.17
10.8
9.2
ml/min/173m2
95.4
96.4
0.16
69
553
(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay
7
30
2.43
1.15
1.0
1.3
—
—
—
0
0
(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture
12
66
1.93
1.15
3.1
2.7
—
—
—
0
0
(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay
7
31
2.35
1.13
1.0
1.1
—
—
—
0
0
(3000494) Fungus identified in Specimen by Culture
14
82
1.83
1.12
1.3
1.6
—
—
—
0
0
(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma
17
106
1.73
1.12
1.3
1.6
—
—
—
0
0
(46236098) ABO and Rh group [Type] in Blood by Confirmatory method
24
166
1.59
1.08
1.9
2.1
—
—
—
0
0
(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma
7
33
2.21
1.08
1.3
2.1
ng/l
40.1
126.8
—
7
28
(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection
7
33
2.21
1.08
1.9
1.7
—
—
—
0
0
(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection
32
238
1.51
1.05
2.4
2.3
—
—
—
0
0
(36660697) Celiac disease serology panel - Serum
15
92
1.74
1.04
1.3
1.2
—
—
—
0
0
(46235355) HIV 1 and 2 tests - Meaningful Use set
40
315
1.46
0.99
2.2
2.2
—
—
—
0
0
(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection
18
119
1.63
0.96
1.7
2.1
—
—
—
0
0
(3029937) Albumin [Presence] in Urine by Test strip
27
197
1.51
0.96
5.3
2.9
estimate
0.0
0.0
0.00
12
78
(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection
6
28
2.22
0.93
1.2
1.5
—
—
—
0
0
(3007853) Bacteria identified in Skin by Aerobe culture
12
72
1.76
0.90
2.4
1.4
—
—
—
0
0
(3002032) Base excess in Venous blood by calculation
8
46
1.80
0.85
1.5
1.7
mmol/l
0.0
2.6
—
8
31
(21494755) Public health laboratory ask at order entry panel
7
121
0.55
0.85
1.0
1.3
—
—
—
0
0
(3045414) Leukocytes [Presence] in Urine
6
32
1.93
0.83
1.3
1.6
—
—
—
0
0
(3013139) Helicobacter pylori Ag [Presence] in Stool
8
48
1.72
0.81
1.1
1.1
—
—
—
0
0
(3012544) pH of Venous blood
8
48
1.72
0.81
1.5
2.3
—
—
—
0
0
(3020682) Albumin/Creatinine [Ratio] in Urine
20
142
1.51
0.80
3.9
4.0
mg/mmol
1.0
15.3
1.35
14
94
(3036481) Cortisol [Moles/volume] in Serum or Plasma
12
75
1.68
0.79
1.3
2.1
nmol/l
373.7
399.1
0.25
12
70
(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
15
100
1.59
0.78
1.5
1.8
—
—
—
0
0
(3006217) Methemoglobin/Hemoglobin.total in Arterial blood
5
24
2.14
0.75
41.6
14.3
%
0.7
0.7
—
5
24
(3028653) Carboxyhemoglobin/Hemoglobin.total in Arterial blood
5
24
2.14
0.75
41.6
14.3
%
1.5
1.5
—
5
24
(3007628) Bicarbonate [Moles/volume] standard in Venous blood
5
25
2.05
0.74
1.4
1.4
mmol/l
23.8
24.6
—
5
25
(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture
32
254
1.39
0.73
2.1
1.7
—
—
—
0
0
(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
11
69
1.67
0.72
1.5
1.5
—
—
—
0
0
(1002224) Polysomnography panel
7
41
1.76
0.71
1.0
1.1
—
—
—
0
0
(3013512) EKG study
20
146
1.46
0.71
2.4
3.3
—
—
—
0
0
(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum
18
129
1.48
0.70
1.3
1.3
u/ml
52.6
7.1
—
6
63
(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma
81
749
1.47
0.69
4.0
3.5
mmol/l
2.7
2.8
0.65
75
708
(3004716) Salmonella sp identified in Stool by Organism specific culture
11
71
1.62
0.65
1.5
1.3
—
—
—
0
0
(3009542) Hematocrit [Volume Fraction] of Blood
84
785
1.49
0.64
16.3
11.4
%
40.5
40.6
0.09
70
656
(3023511) Choriogonadotropin [Units/volume] in Urine
8
50
1.65
0.63
1.3
1.2
—
—
—
0
0
(3022621) pH of Urine by Test strip
8
51
1.62
0.62
1.6
2.2
—
—
—
0
0
(3003458) Phosphate [Moles/volume] in Serum or Plasma
11
72
1.59
0.62
2.5
5.5
mmol/l
1.0
1.0
0.07
11
65
(40768793) Breast Pathology biopsy report
0
22
0.00
0.60
0.0
1.1
—
—
—
0
0
(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting
77
714
1.37
0.57
3.2
3.1
mmol/l
1.1
1.2
1.43
72
674
(3003694) ABO and Rh group [Type] in Blood
23
287
0.74
0.56
1.8
1.7
—
—
—
0
0
(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma
12
83
1.51
0.55
1.1
1.4
—
—
—
0
0
(3028707) Methadone [Presence] in Urine by Screen method
6
39
1.57
0.54
1.5
1.6
—
—
—
0
0
(3026008) Bacteria identified in Urine by Culture
26
211
1.32
0.51
2.4
2.4
—
—
—
0
0
(3019309) Folate [Moles/volume] in Red Blood Cells
12
85
1.47
0.49
1.5
1.7
nmol/l
1151.7
1067.5
0.14
12
63
(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
10
68
1.52
0.49
1.4
1.5
—
—
—
0
0
(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma
79
741
1.34
0.49
3.6
3.3
mmol/l
1.5
1.5
0.10
74
700
(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma
15
112
1.40
0.48
2.0
3.5
ng/l
8.5
32.0
—
10
60
(3002256) Pathology report gross observation
12
86
1.45
0.47
1.1
1.2
—
—
—
0
0
(3012095) Magnesium [Moles/volume] in Serum or Plasma
13
95
1.42
0.46
2.1
3.7
mmol/l
0.8
0.8
0.05
13
90
(40760892) CBC W Ordered Manual Differential panel - Blood
24
196
1.30
0.45
5.5
4.5
—
—
—
0
0
(3001019) Free T4 and TSH panel - Serum or Plasma
8
55
1.49
0.44
1.9
1.8
—
—
—
0
0
(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip
35
301
1.25
0.44
4.9
2.9
—
—
—
0
0
(3002179) Metamyelocytes/100 leukocytes in Blood
8
59
1.39
0.42
4.8
3.5
—
0.1
—
0
11
(3019900) Cholesterol [Moles/volume] in Serum or Plasma
79
746
1.30
0.42
3.7
3.3
mmol/l
4.5
4.7
0.83
74
708
(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain
5
33
1.54
0.42
1.0
1.4
—
—
—
0
0
(3030905) Polymorphonuclear cells [#/volume] in Blood
0
17
0.00
0.41
0.0
4.1
—
3.9
—
0
17
(3032035) Polymorphonuclear cells/100 leukocytes in Blood
0
17
0.00
0.41
0.0
4.1
—
52.1
—
0
17
(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection
19
152
1.31
0.41
1.8
2.2
—
—
—
0
0
(3051387) C reactive protein [Mass/volume] in Capillary blood
0
18
0.00
0.40
0.0
4.3
—
22.3
—
0
10
(3042936) Bacteria identified in Isolate by Culture
12
89
1.40
0.40
3.3
2.6
—
—
—
0
0
(40761536) Microorganisms panel - Urine sediment
9
68
1.36
0.39
4.4
2.7
—
—
—
0
0
(1001926) Buprenorphine [Presence] in Urine by Screen method
9
68
1.36
0.39
1.3
1.4
—
—
—
0
0
(4010399)
6
41
1.49
0.37
2.2
1.3
—
—
—
0
0
(3050129) First trimester maternal screen panel - Serum or Plasma
6
86
0.68
0.35
1.5
1.4
—
—
—
0
0
(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
77
731
1.25
0.34
4.4
3.9
—
—
—
0
0
(3027008) Opiates [Presence] in Urine
11
83
1.37
0.33
1.3
1.4
—
—
—
0
0
(3028300) Cannabinoids [Presence] in Urine
11
83
1.37
0.33
1.3
1.4
—
—
—
0
0
(3000764) Benzodiazepines [Presence] in Urine
11
84
1.35
0.31
1.3
1.4
—
—
—
0
0
(3044640) Blood type and Crossmatch panel - Blood
26
224
1.22
0.31
2.3
2.2
—
—
—
0
0
(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture
7
54
1.32
0.31
1.3
1.5
—
—
—
0
0
(3016879) Cocaine [Presence] in Urine
10
79
1.30
0.23
1.3
1.4
—
—
—
0
0
(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay
5
42
1.20
0.22
1.2
2.2
—
—
—
0
0
(3013290) Carbon dioxide [Partial pressure] in Blood
0
11
0.00
0.21
0.0
3.5
—
5.0
—
0
11
(3027315) Oxygen [Partial pressure] in Blood
0
11
0.00
0.21
0.0
3.5
—
9.5
—
0
11
(3035637) Corticotropin [Mass/volume] in Plasma
0
11
0.00
0.21
0.0
1.5
—
—
—
0
0
(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method
0
11
0.00
0.21
0.0
1.2
—
—
—
0
0
(1616796) Gas panel - Central venous blood
0
11
0.00
0.21
0.0
1.9
—
—
—
0
0
(42529200) Cancer Ag 15-3 [Units/volume] in Serum or Plasma by Immunoassay
0
11
0.00
0.21
0.0
3.8
—
149.6
—
0
11
(3012447) Hantavirus puumala IgG Ab [Titer] in Serum
0
10
0.00
0.21
0.0
1.1
—
—
—
0
0
(3006588) Cancer Ag 15-3 [Units/volume] in Serum or Plasma
0
10
0.00
0.21
0.0
2.8
—
17.6
—
0
10
(40767503) Oxygen content in Capillary blood by calculation
0
12
0.00
0.21
0.0
2.5
—
16.6
—
0
5
(3038515) Glucose [Moles/volume] in Venous blood
0
12
0.00
0.21
0.0
2.3
—
6.5
—
0
12
(3008037) Lactate [Moles/volume] in Venous blood
0
12
0.00
0.21
0.0
2.3
—
1.3
—
0
12
(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence
0
13
0.00
0.21
0.0
1.2
—
—
—
0
0
(3001079) Blood group antibody screen [Presence] in Serum or Plasma
35
378
0.88
0.18
3.6
4.2
—
—
—
0
0
(3048929) Epstein Barr virus Ab [Presence] in Serum
7
60
1.18
0.18
1.3
1.2
—
—
—
0
0
(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma
6
75
0.79
0.16
1.5
1.6
—
—
—
0
0
(3027944) Amphetamines [Presence] in Urine
10
84
1.21
0.14
1.3
1.4
—
—
—
0
0
(3033319) Streptococcus pyogenes Ag [Presence] in Throat
19
172
1.13
0.12
1.4
1.5
—
—
—
0
0
(3003338) MCHC [Mass/volume]
76
741
1.11
0.12
18.4
12.7
g/l
332.0
333.7
0.93
76
736
(3041096) Erythrocytes [Presence] in Urine by Automated
26
241
1.11
0.12
3.5
2.6
—
—
—
0
0
(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma
5
44
1.14
0.10
1.2
1.5
—
—
—
0
0
(3019225) pH of Specimen
5
47
1.07
0.09
1.2
5.2
—
—
—
0
0
(43054914) Glucose tolerance 2 hours panel - Serum or Plasma
12
107
1.14
0.09
2.3
2.0
—
—
—
0
0
(3017143) Hepatitis C virus Ab [Presence] in Serum
17
156
1.11
0.08
1.4
1.6
—
—
—
0
0
(3021387) Prolactin [Units/volume] in Serum or Plasma
6
58
1.04
0.08
4.3
1.4
mu/l
271.8
252.2
—
6
52
(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma
6
58
1.04
0.08
1.5
1.6
—
—
—
0
0
(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep
18
192
0.92
0.06
2.1
1.4
—
—
—
0
0
(3019832) Treponema pallidum Ab [Presence] in Serum
23
220
1.06
0.04
1.7
1.8
—
—
—
0
0
(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma
12
127
0.94
0.02
1.3
1.5
—
—
—
0
0
(3021879) Hepatitis B virus core Ab [Presence] in Serum
11
104
1.06
0.01
1.4
1.4
—
—
—
0
0
(3019284) Hepatitis B virus surface Ag [Presence] in Serum
26
254
1.03
0.00
1.5
1.7
—
—
—
0
0
(1761868) Lipid panel - Serum or Plasma
31
313
0.99
0.00
1.9
2.3
—
—
—
0
0
(3003181) Sodium [Moles/volume] in Urine
0
8
0.00
0.00
0.0
2.3
—
57.9
—
0
8
(40760888) Immunoglobulin light chains.free panel - Serum
0
8
0.00
0.00
0.0
7.8
—
—
—
0
0
(3013327) Hepatitis A virus IgM Ab [Presence] in Serum
0
9
0.00
0.00
0.0
1.1
—
—
—
0
0
(3041354) Potassium [Moles/volume] in Venous blood
0
8
0.00
0.00
0.0
2.4
—
3.9
—
0
8
(3035285) Chloride [Moles/volume] in Venous blood
0
8
0.00
0.00
0.0
2.4
—
106.4
—
0
8
(40765089) Chromosome analysis panel - Blood by G-banded
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay
0
8
0.00
0.00
0.0
1.4
—
—
—
0
0
(3032773) Endomysium IgG Ab [Titer] in Serum
0
9
0.00
0.00
0.0
1.1
—
—
—
0
0
(3022806) Fractional oxyhemoglobin in Capillary blood
0
8
0.00
0.00
0.0
2.9
—
89.1
—
0
8
(3028334) Neisseria gonorrhoeae [Presence] in Specimen by Organism specific culture
0
8
0.00
0.00
0.0
1.1
—
—
—
0
0
(3033705) Calcium.ionized [Moles/volume] in Venous blood
0
8
0.00
0.00
0.0
2.4
—
—
—
0
0
(3028271) Lactate [Moles/volume] in Capillary blood
0
9
0.00
0.00
0.0
2.8
—
1.8
—
0
9
(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence
0
8
0.00
0.00
0.0
1.8
—
—
—
0
0
(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma
6
62
0.97
0.00
5.8
4.7
—
—
—
0
0
(3010503) CD19 cells [#/volume] in Blood
0
5
0.00
0.00
0.0
1.4
—
0.1
—
0
5
(3016724) Homocysteine [Moles/volume] in Serum or Plasma
0
7
0.00
0.00
0.0
1.3
—
10.9
—
0
7
(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma
6
68
0.87
0.00
1.2
1.4
—
—
—
0
0
(3036782) Glucose [Moles/volume] in Pleural fluid
0
5
0.00
0.00
0.0
1.0
—
7.8
—
0
5
(3010838) Calcium [Moles/time] in 24 hour Urine
0
6
0.00
0.00
0.0
1.5
—
—
—
0
0
(1175426) CD3 cells/100 lymphocytes in Blood
0
5
0.00
0.00
0.0
1.4
—
83.0
—
0
5
(3045066) Thymidine kinase [Enzymatic activity/volume] in Serum
0
6
0.00
0.00
0.0
1.2
—
39.7
—
0
6
(3046294) Neutrophil cytoplasmic Ab.classic [Titer] in Serum
0
7
0.00
0.00
0.0
1.3
—
—
—
0
0
(3009550) Parvovirus B19 IgG Ab [Titer] in Serum
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age
6
68
0.87
0.00
1.2
1.4
—
—
—
0
0
(3005757) Coagulation factor V activity actual/normal in Platelet poor plasma by Coagulation assay
0
5
0.00
0.00
0.0
3.0
—
99.8
—
0
5
(3021901) Oxygen saturation in Capillary blood
0
7
0.00
0.00
0.0
1.4
—
—
—
0
0
(3025159) Blasts/100 leukocytes in Blood
6
60
1.00
0.00
6.3
3.6
—
0.0
—
0
13
(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal
0
5
0.00
0.00
0.0
1.8
—
—
—
0
0
(3026389) Candida sp identified in Specimen by Organism specific culture
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
(3039443) Prostate specific Ag panel - Serum or Plasma
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
(3029080) Hemoglobin [Entitic mass] in Reticulocytes
0
7
0.00
0.00
0.0
1.1
—
32.3
—
0
7
(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood
0
6
0.00
0.00
0.0
1.5
—
—
—
0
0
(3008898) HLA-B27 [Presence]
5
57
0.87
0.00
1.6
1.1
—
—
—
0
0
(44806071)
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3037756) Immunofixation for Serum or Plasma
0
5
0.00
0.00
0.0
2.0
—
—
—
0
0
(4146454)
0
7
0.00
0.00
0.0
2.7
—
—
—
0
0
(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma
6
68
0.87
0.00
1.2
1.4
—
—
—
0
0
(21494890) Protein electrophoresis panel - 24 hour Urine
0
6
0.00
0.00
0.0
1.5
—
—
—
0
0
(3045142) Bone marrow Pathology biopsy report
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight
6
68
0.87
0.00
1.2
1.4
—
—
—
0
0
(3043410) Blood group antigens tested for on Red Blood Cells
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
(44816893) Food Allergen Mix 50 (Kiwi+Pineapple+Banana+Mango) IgE Ab [Units/volume] in Serum by Multidisk
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3036071) Salmonella sp Ab [Titer] in Serum
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3018658) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3007847) Interleukin 2 Receptor Soluble [Units/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
2.8
—
972.8
—
0
5
(3007821) Glucose [Moles/volume] in Serum or Plasma --baseline
0
6
0.00
0.00
0.0
1.3
—
5.8
—
0
6
(3017817) Protein [Mass] in Urine collected for unspecified duration
0
7
0.00
0.00
0.0
2.0
—
—
—
0
0
(3016616) Dehydroepiandrosterone sulfate (DHEA-S) [Moles/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
1.2
—
9.3
—
0
5
(21494434) Karyotype in Bone marrow
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(1617658) Protocol used for examination of sentinel lymph nodes
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
Mortality – FinRegistry
↥Association
Association between endpoint F5_SLEEPWALKING and mortality.
Females
No dataMales
No dataMortality risk
Mortality risk for people of age
years, who have F5_SLEEPWALKING.| N-year risk | Females | Males |
|---|---|---|
| 1 | No data | No data |
| 5 | No data | No data |
| 10 | No data | No data |
| 15 | No data | No data |
| 20 | No data | No data |
Relationships between endpoints
↥Index endpoint: F5_SLEEPWALKING – Sleepwalking [somnambulism]
GWS hits: -
Endpoint
Case Overlap
Survival Analysis
Genetic Correlations
Genetic Signals
N (Jaccard index)
HR [CI]
Extremity
rg [CI]
Extremity
Hits
Coloc Hits
FinRegistry
FinnGen
FinRegistry
FinnGen
FinnGen
Loading data